Last week’s “listening session” on pharmaceutical competition, hosted jointly by the U.S. Justice Department (DOJ) and Federal Trade Commission (FTC), may go down as an important precursor to the Trump administration’s promised campaign to lower drug prices. While billed as a fact-finding exercise, the discussion revealed competing visions to reform the U.S. pharmaceutical ecosystem, with ... First Impressions from the DOJ/FTC Listening Session on Drug-Price Competition The post First...| Truth on the Market
Our umbrella review that revealed no links between serotonin and depression has caused shock waves among the general public, but been dismissed as old news by psychiatric opinion leaders. This disj…| Joanna Moncrieff
Trump’s lies are like zombies. Fact-checkers keep killing them, but he keeps bringing them back to life — and repeating them over and over again. The only antidote is the truth — repeated over and over again. Steven Harper is following the pandemic for Moyers on Democracy.| BillMoyers.com